These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion. Själander S; Svensson PJ; Friberg L Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562 [TBL] [Abstract][Full Text] [Related]
4. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry. Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604 [TBL] [Abstract][Full Text] [Related]
6. Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation - the FinCV-4 study. Jaakkola S; Kiviniemi TO; Jaakkola J; Pouru JP; Nuotio I; Vasankari T; Hartikainen JEK; Airaksinen KEJ Ann Med; 2022 Dec; 54(1):1452-1458. PubMed ID: 35594342 [TBL] [Abstract][Full Text] [Related]
7. CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion. Falsetti L; Viticchi G; Tarquinio N; Silvestrini M; Capeci W; Balloni A; Catozzo V; Gentile A; Pellegrini F J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):636-41. PubMed ID: 24978663 [TBL] [Abstract][Full Text] [Related]
8. CHA Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228 [TBL] [Abstract][Full Text] [Related]
9. The Value of the CHADS Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449 [TBL] [Abstract][Full Text] [Related]
10. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809 [TBL] [Abstract][Full Text] [Related]
11. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981 [TBL] [Abstract][Full Text] [Related]
12. CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: Systematic review and individual patient pooled meta-analysis. Vitali F; Serenelli M; Airaksinen J; Pavasini R; Tomaszuk-Kazberuk A; Mlodawska E; Jaakkola S; Balla C; Falsetti L; Tarquinio N; Ferrari R; Squeri A; Campo G; Bertini M Clin Cardiol; 2019 Mar; 42(3):358-364. PubMed ID: 30597581 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study). Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Ylitalo A; Airaksinen KE Am J Cardiol; 2016 Apr; 117(8):1294-8. PubMed ID: 26892448 [TBL] [Abstract][Full Text] [Related]
15. Pre-admission CHADS2, CHA2DS2-VASc, and R2CHADS2 Scores on Severity and Functional Outcome in Acute Ischemic Stroke with Atrial Fibrillation. Tanaka K; Yamada T; Torii T; Furuta K; Matsumoto S; Yoshimura T; Takase K; Wakata Y; Nakashima N; Kira J; Murai H J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1629-35. PubMed ID: 25906940 [TBL] [Abstract][Full Text] [Related]
16. CHA Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320 [TBL] [Abstract][Full Text] [Related]
17. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126 [TBL] [Abstract][Full Text] [Related]
18. The CHA Fumagalli S; Pelagalli G; Montorzi RF; Marozzi I; Migliorini M; D'Andria MF; Lip GYH; Marchionni N Eur J Intern Med; 2020 Dec; 82():56-61. PubMed ID: 32709545 [TBL] [Abstract][Full Text] [Related]
20. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study. Hu WS; Lin CL Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]